Abstract A117: Evaluation of Nab-Sirolimus in Combination with PI3K Pathway Inhibitors to Overcome PI3K/mTOR Resistance in PI3K-mutant Breast Cancer Cell Lines
Molecular Cancer Therapeutics(2023)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Molecular Cancer Therapeutics(2023)